Suppr超能文献

腺相关病毒的DNA改组产生功能多样的病毒后代。

DNA shuffling of adeno-associated virus yields functionally diverse viral progeny.

作者信息

Koerber James T, Jang Jae-Hyung, Schaffer David V

机构信息

Department of Chemical Engineering, University of California at Berkeley, Berkeley, California 94720-1462, USA.

出版信息

Mol Ther. 2008 Oct;16(10):1703-9. doi: 10.1038/mt.2008.167. Epub 2008 Aug 26.

Abstract

Adeno-associated virus (AAV) vectors are extremely effective gene-delivery vehicles for a broad range of applications. However, the therapeutic efficacy of these and other vectors is currently limited by barriers to safe, efficient gene delivery, including pre-existing antiviral immunity, and infection of off-target cells. Recently, we have implemented directed evolution of AAV, involving the generation of randomly mutagenized viral libraries based on serotype 2 and high-throughput selection, to engineer enhanced viral vectors. Here, we significantly extend this capability by performing high-efficiency in vitro recombination to create a large (10(7)), diverse library of random chimeras of numerous parent AAV serotypes (AAV1, 2, 4-6, 8, and 9). In order to analyze the extent to which such highly chimeric viruses can be viable, we selected the library for efficient viral packaging and infection, and successfully recovered numerous novel chimeras. These new viruses exhibited a broad range of cell tropism both in vitro and in vivo and enhanced resistance to human intravenous immunoglobulin (IVIG), highlighting numerous functional differences between these chimeras and their parent serotypes. Thus, directed evolution can potentially yield unlimited numbers of new AAV variants with novel gene-delivery properties, and subsequent analysis of these variants can further extend basic knowledge of AAV biology.

摘要

腺相关病毒(AAV)载体是用于广泛应用的极其有效的基因递送工具。然而,目前这些载体和其他载体的治疗效果受到安全、高效基因递送障碍的限制,包括预先存在的抗病毒免疫以及脱靶细胞的感染。最近,我们实施了AAV的定向进化,包括基于2型血清型生成随机诱变的病毒文库并进行高通量筛选,以构建增强型病毒载体。在此,我们通过进行高效体外重组来显著扩展这一能力,从而创建一个大型(10^7)、多样的文库,该文库包含众多亲本AAV血清型(AAV1、2、4 - 6、8和9)的随机嵌合体。为了分析这种高度嵌合的病毒能够存活的程度,我们对该文库进行高效病毒包装和感染筛选,并成功获得了众多新型嵌合体。这些新病毒在体外和体内均表现出广泛的细胞嗜性,并且对人静脉注射免疫球蛋白(IVIG)具有增强的抗性,突出了这些嵌合体与其亲本血清型之间的众多功能差异。因此,定向进化有可能产生数量无限的具有新型基因递送特性的新AAV变体,并且对这些变体的后续分析可以进一步扩展AAV生物学的基础知识。

相似文献

1
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny.
Mol Ther. 2008 Oct;16(10):1703-9. doi: 10.1038/mt.2008.167. Epub 2008 Aug 26.
3
Impact of the Assembly-Activating Protein on Molecular Evolution of Synthetic Adeno-Associated Virus Capsids.
Hum Gene Ther. 2019 Jan;30(1):21-35. doi: 10.1089/hum.2018.085. Epub 2018 Dec 18.
5
Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Methods Mol Biol. 2011;709:127-39. doi: 10.1007/978-1-61737-982-6_8.
6
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3946-51. doi: 10.1073/pnas.0813207106. Epub 2009 Feb 20.
8
Chimeric AAV Cap sequences alter gene transduction.
Virology. 2009 Apr 10;386(2):237-48. doi: 10.1016/j.virol.2009.01.012. Epub 2009 Feb 15.
10
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles.
Mol Ther. 2008 Jul;16(7):1252-60. doi: 10.1038/mt.2008.100. Epub 2008 May 20.

引用本文的文献

2
Directed evolution of novel AAV variants using the MCMS library for enhanced CNS tropism and reduced liver targeting in mice.
Mol Ther Methods Clin Dev. 2025 Jun 25;33(3):101522. doi: 10.1016/j.omtm.2025.101522. eCollection 2025 Sep 11.
4
Advances in AAV capsid engineering: Integrating rational design, directed evolution and machine learning.
Mol Ther. 2025 May 7;33(5):1937-1945. doi: 10.1016/j.ymthe.2025.03.056. Epub 2025 Apr 1.
7
Adeno-associated viral vector targeted evolution for neurofibromatosis gene delivery.
Trends Mol Med. 2025 Apr;31(4):388-398. doi: 10.1016/j.molmed.2025.01.004. Epub 2025 Jan 30.
9
AAVolve: Concatenated long-read deep sequencing enables whole capsid tracking during shuffled AAV library selection.
Mol Ther Methods Clin Dev. 2024 Oct 4;32(4):101351. doi: 10.1016/j.omtm.2024.101351. eCollection 2024 Dec 12.
10
Engineered AAV capsid transport mutants overcome transduction deficiencies in the aged CNS.
Mol Ther Nucleic Acids. 2024 Sep 12;35(4):102332. doi: 10.1016/j.omtn.2024.102332. eCollection 2024 Dec 10.

本文引用的文献

1
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles.
Mol Ther. 2008 Jul;16(7):1252-1260. doi: 10.1038/mt.2008.100. Epub 2016 Dec 8.
2
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
4
Structure of adeno-associated virus serotype 8, a gene therapy vector.
J Virol. 2007 Nov;81(22):12260-71. doi: 10.1128/JVI.01304-07. Epub 2007 Aug 29.
5
Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
Mol Ther. 2007 Nov;15(11):1955-62. doi: 10.1038/sj.mt.6300293. Epub 2007 Aug 28.
7
CD8(+) T-cell responses to adeno-associated virus capsid in humans.
Nat Med. 2007 Apr;13(4):419-22. doi: 10.1038/nm1549. Epub 2007 Mar 18.
9
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.
J Virol. 2006 Dec;80(23):11556-70. doi: 10.1128/JVI.01536-06. Epub 2006 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验